Today, Carpenter's lab continues those
efforts as her team works to
accelerate drug discovery by writing software to automatically analyze the deluge of cellular images generated by today's powerful, robotic microscopes.
«One of the ways to truly realize the full value of human genetics, is to make our research synergistic with
drug development
efforts where target
discovery, validation and prioritization
efforts can be
accelerated,» said Kari Stefansson, M.D., Dr. Med., founder and CEO at deCODE Genetics.